Management of ME/CFS As well as there being insufficient diagnostic testing available for ME/CFS patients, there are also no effective therapies (12, 26, 60, 488, 529531) and few established non-pharmacological treatments for ME/CFS (29)
Patients ask me this constantly, and the honest answer is economics
Healthcare systems in other countries often negotiate directly with drug manufacturers, leading to heavily capped prices
Edited by Professor Alexei Verkhratsky Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
As an experimental metabolic research peptide, it has not undergone large-scale regulatory approval studies
Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells
